Vig Pamela
SEC CIK 1780069 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MIRM | Mirum Pharmaceuticals, Inc. | Head of Research, Development | 27.4K | — | $1.20M | 16 | 2021-09-29 | 2024-06-24 |
Most active insiders at MIRM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Peetz Christopher | CEO, Dir | — | $16.29M |
| 2 | GREY MICHAEL G | Dir | — | $11.10M |
| 3 | Heron Patrick J | Dir | $9.00M | — |
| 4 | Howe Jolanda | SVP, Gbl Ctrl | — | $5.55M |
| 5 | BJERKHOLT ERIC | CFO | — | $3.56M |
| 6 | Radovich Peter | Pres AND COO | — | $2.32M |
| 7 | Ramasastry Saira | Dir | — | $1.92M |
| 8 | Quan Joanne | Chief MEDICAL Off | — | $1.46M |
| 9 | Cardon Lon | Dir | — | — |
| 10 | Fischer Laurent | Dir | — | — |
Vig Pamela made no open-market trades at MIRM in the last 12 months.
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-25 | 2024-06-24 | MIRM | Mirum Pharmaceuticals, Inc. | Vig Pamela | CSO | S - Sale+OE | $34.00 | -30.6K | 27.4K | -53% | -$1.04M |
| D | 2024-06-25 | 2024-06-24 | MIRM | Mirum Pharmaceuticals, Inc. | Vig Pamela | CSO | M - OptEx | $2.94 | +30.6K | 58.0K | +112% | +$89.8K |
| 2024-05-16 | 2024-05-10 | MIRM | Mirum Pharmaceuticals, Inc. | Vig Pamela | CSO | A - Grant | $21.05 | +94 | 27.4K | +0.3% | +$1,979 | |
| 2024-03-18 | 2023-01-09 | MIRM | Mirum Pharmaceuticals, Inc. | Vig Pamela | CSO | S - Sale | $20.62 | -1,379 | 27.3K | -5% | -$28.4K | |
| 2024-02-05 | 2024-02-02 | MIRM | Mirum Pharmaceuticals, Inc. | Vig Pamela | CSO | S - Sale | $26.19 | -1,214 | 28.7K | -4% | -$31.8K | |
| 2024-01-09 | 2024-01-08 | MIRM | Mirum Pharmaceuticals, Inc. | Vig Pamela | HEAD OF RESEARCH, DEVELOPMENT | S - Sale | $28.03 | -1,408 | 29.9K | -4% | -$39.5K | |
| 2023-11-15 | 2023-11-10 | MIRM | Mirum Pharmaceuticals, Inc. | Vig Pamela | Head of Research, Development | A - Grant | $22.29 | +527 | 31.3K | +2% | +$11.7K | |
| 2023-07-05 | 2023-07-03 | MIRM | Mirum Pharmaceuticals, Inc. | Vig Pamela | Head of Research, Development | S - Sale | $25.65 | -1,425 | 30.8K | -4% | -$36.6K | |
| 2023-05-19 | 2023-05-10 | MIRM | Mirum Pharmaceuticals, Inc. | Vig Pamela | Head of Research, Development | A - Grant | $16.92 | +684 | 32.2K | +2% | +$11.6K | |
| D | 2023-02-02 | 2023-01-31 | MIRM | Mirum Pharmaceuticals, Inc. | Vig Pamela | Head of Research, Development | A - Grant | $0.00 | +9,625 | 31.5K | +44% | $0 |
| 2022-11-14 | 2022-11-10 | MIRM | Mirum Pharmaceuticals, Inc. | Vig Pamela | Head of Research, Development | A - Grant | $17.05 | +660 | 21.9K | +3% | +$11.3K | |
| 2022-05-12 | 2022-05-10 | MIRM | Mirum Pharmaceuticals, Inc. | Vig Pamela | Head of Research, Development | A - Grant | $13.57 | +807 | 21.2K | +4% | +$11.0K | |
| D | 2022-01-07 | 2022-01-06 | MIRM | Mirum Pharmaceuticals, Inc. | Vig Pamela | CSO | A - Grant | $0.00 | +10.0K | 20.4K | +96% | $0 |
| 2021-11-15 | 2021-11-10 | MIRM | Mirum Pharmaceuticals, Inc. | Vig Pamela | CSO | A - Grant | $13.52 | +768 | 10.4K | +8% | +$10.4K | |
| 2021-10-01 | 2021-09-29 | MIRM | Mirum Pharmaceuticals, Inc. | Vig Pamela | CSO | A - Grant | $0.00 | +8,125 | 11.0K | +280% | $0 | |
| 2021-10-01 | 2021-10-01 | MIRM | Mirum Pharmaceuticals, Inc. | Vig Pamela | CSO | S - Sale | $19.26 | -1,364 | 9,667 | -12% | -$26.3K |
Purchase Sale Sale after option exercise All abbreviations